Balentine LLC bought a new position in shares of Revvity, Inc. (NYSE:RVTY – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,002 shares of the company’s stock, valued at approximately $219,000.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. Byrne Asset Management LLC acquired a new position in shares of Revvity during the 4th quarter worth approximately $1,112,000. BNP Paribas Financial Markets bought a new position in shares of Revvity during the fourth quarter valued at $12,039,000. State of Michigan Retirement System bought a new position in shares of Revvity during the fourth quarter valued at $3,688,000. Gulf International Bank UK Ltd bought a new position in shares of Revvity during the fourth quarter valued at $1,136,000. Finally, Russell Investments Group Ltd. bought a new position in shares of Revvity during the fourth quarter valued at $10,291,000. Institutional investors own 86.65% of the company’s stock.
Revvity Stock Down 0.7 %
RVTY opened at $111.89 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.23 and a quick ratio of 1.92. The company’s 50-day moving average is $104.57 and its 200 day moving average is $102.50. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $131.96. The firm has a market capitalization of $13.81 billion, a P/E ratio of 92.47, a PEG ratio of 2.93 and a beta of 1.09.
Revvity Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Shareholders of record on Friday, July 19th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.25%. The ex-dividend date is Friday, July 19th. Revvity’s dividend payout ratio is 23.14%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on RVTY shares. Robert W. Baird increased their price objective on shares of Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 30th. KeyCorp increased their price objective on shares of Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. TD Cowen increased their price objective on shares of Revvity from $123.00 to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, April 30th. Raymond James increased their price objective on shares of Revvity from $106.00 to $127.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. Finally, Barclays increased their price objective on shares of Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. Six investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Revvity currently has a consensus rating of “Moderate Buy” and an average price target of $118.17.
Get Our Latest Analysis on RVTY
About Revvity
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Featured Articles
- Five stocks we like better than Revvity
- What is a buyback in stocks? A comprehensive guide for investors
- Snowflake is Melting… Up, With a Double-Digit Upside Potential
- Roth IRA Calculator: Calculate Your Potential Returns
- Micron Stock: Even With A 150% Gain, Analysts Want More
- What Are Dividend Challengers?
- TD Bank Q2 Earnings: Record Highs and Regulatory Hurdles
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity, Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.